Nigel McCracken
Chief Operating Officer at VIRAX BIOLABS GROUP LIMITED
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nelson Haight | M | 59 | - | |
| Evan Norton | M | 49 | - | |
| Martin Olin | M | 55 | 3 years | |
| James Foster | M | 37 | 11 years | |
| Mark Ternouth | M | 56 | - | |
| Yair Erez | M | 50 | - | |
| Pierre Jullian | M | - |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 6 years |
| Gayle Mills | F | 69 | 3 years | |
| Jason Davis | M | 52 | 2 years | |
| Cristina Oliva | M | - | 2 years | |
| Anders Lennart Tullgren | M | 63 | 2 years | |
| Tomasz George | M | 40 | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cameron Shaw | M | 37 | 10 years | |
| James Bradley Lorens | M | - | 14 years | |
| Richard Stuart Godfrey | M | 58 | 13 years | |
| Stener Kvinnsland | M | 76 | 7 years | |
| Hani Gabra | M | - | 3 years | |
| E. Gwyn Thomas | M | - | 1 years | |
| Andres McAllister | M | 68 |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 11 years |
| Alison Messom | M | 52 | 2 years | |
| Christine Deuschel Cornioley | M | - |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 23 years |
| Debbie Molyneux | F | - | 4 years | |
| Gro Gausdal | M | - | 8 years | |
| Chris Freitag | M | 58 |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 12 | 50.00% |
| United Kingdom | 8 | 33.33% |
| Switzerland | 4 | 16.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Nigel McCracken
- Personal Network
